Editas Medicine
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $61 | $513 | $1,135 | $60,049 |
Gross Profit | -1,538 | -907 | -274 | 58,583 |
EBITDA | -60,542 | -70,483 | -65,581 | -22,496 |
EBIT | -62,141 | -71,903 | -66,990 | -23,962 |
Net Income | -62,141 | -67,607 | -61,950 | -18,874 |
Net Change In Cash | 61 | 513 | 1,135 | 60,049 |
Free Cash Flow | -55,509 | -60,556 | -51,743 | -23,547 |
Cash | 95,832 | 64,441 | 69,227 | 123,652 |
Basic Shares | 82,485 | 82,310 | 81,938 | 81,710 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $78,123 | $19,712 | $25,544 | $90,732 |
Gross Profit | -99,528 | 19,712 | 25,544 | 90,732 |
EBITDA | -163,117 | -219,613 | -188,093 | -130,881 |
EBIT | -169,181 | -225,950 | -193,146 | -134,840 |
Net Income | -153,219 | -204,352 | -185,107 | -109,412 |
Net Change In Cash | 78,123 | 19,712 | 25,544 | 90,732 |
Cost of Revenue | -61,997 | 63,837 | -96,243 | |
Free Cash Flow | -136,897 | -181,467 | -171,780 | -187,005 |
Cash | 123,652 | 141,522 | 203,519 | 139,682 |
Basic Shares | 75,965 | 68,664 | 67,619 | 58,609 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.75 |
2024-06-30 | -$0.82 |
2024-03-31 | -$0.76 |
2023-12-31 | -$0.23 |
